There have been recent developments in pneumococcal protein vaccines, with research focusing on various aspects such as protein interactions and next-generation mRNA vaccines. New pneumococcal vaccines, including a 25-valent and a 15-valent version, are showing promise, with one of them being made available to children. The field of vaccine development is advancing, with multiple approaches being explored, including mRNA technology and monoclonal antibodies.